Invacare reported strong financial results for 2020, with higher profitability, expanded gross margins, reduced SG&A expenses, and breakeven cash flow. Despite pandemic challenges, the company launched new products, strengthened its financial flexibility, and improved its manufacturing network. For 2021, Invacare expects constant currency net sales growth of 4% to 7%, a 41% increase in adjusted EBITDA to $45 million, and free cash flow generation of $5 million. The company highlights its commitment to serving a persistent market, simplifying its business, and investing in innovation and efficiency. Invacare's focus on ESG initiatives aligns with its mission of enhancing independence and healthcare solutions while engaging its workforce and fostering social responsibility. The company anticipates strong sales growth in the second half of 2021, driven by new products and pent-up demand.